Credit: Original article can be found here
Red Light Holland Corp. TRIP (FSE:4YX) TRUFF announced updates regarding its manufacturing plans to create homogenized natural psilocybin microdosing capsules.
CCrest Laboratories Inc., a Montreal-based cGMP pharmaceutical laboratory that holds a Controlled Drugs & Substances Dealer’s License from Health Canada, has completed dehydration and homogenization and has produced a Certificate of Analysis of Red Light Holland’s natural psilocybin truffles grown in the Netherlands that were imported to Canada under a Health Canada license.
Further, the company has selected and sourced child proof packaging for its microdosing capsules. The packaging includes a HDPE plastic bottle with Child Resistant Closures and an auto lock external box. As disclosed previously, and subject to obtaining Health Canada’s approval for export, the natural psilocybin microdosing capsules are intended to be distributed in Australasia by NUBU Pharmaceuticals, a medical cannabis company based in New Zealand with distribution ties to Australia.
“We are very hopeful that our prestigious partnerships with CCrest and NUBU Pharmaceuticals will bring about an excellent natural psilocybin microdosing product that has the potential of helping many people,” stated Todd Shapiro, Red Light Holland CEO and director. “We will continue to carefully yet aggressively seek legal opportunities to increase responsible access to natural psilocybin around the world.”
Australia has recently, on February 3, 2023, announced a down-listing of psilocybin in its list of controlled substances to allow psychiatrists to prescribe psilocybin to patients suffering from treatment resistant depression. The change in scheduling was announced to take effect on July 1, 2023.
Photo by Louis Reed on Unsplash
High-Profile Highs: How Celebrity Advocacy Is Transforming Society’s Views On Psychedelics And Cannabis
Red Light Holland’s Q3 2023 Financials: Expanded Farms Division, Home Grow Kits & Revenue Increase